Texas Pancreatic Cancer Lawyer: Persons Taking Diabetes Drugs Including Januvia, Janument, Victoza, Byetta, Onglyza, Tradjenta, Bydureon, Oseni, and Other Diabetes Drugs Should Be Aware of Cancer Risk by Texas Pancreatic Cancer Lawyer Jason S. Coomer
Recent scientific studies have shown that several diabetes drugs may 
cause an increased risk of pancreatic cancer.  Persons taking Januvia, 
Janument, Victoza, Byetta, Onglyza, Tradjenta, Bydureon, Oseni, and 
other diabetes drugs should be aware of the potential dangers.  If you are taking these diabetes drugs, it is important to discuss the potential health risks with your medical providers and to be aware of any symptoms of pancreatic cancer you may experience.  For more information on this topic, please go to the following web page: 
Pancreatic Cancer Health Risk Caused by Diabetes Drugs.
Pancreatic Cancer Detection: Understanding and Identifying Symptoms of 
Pancreatic Cancer Can Be Important In Early Detection and Treatment of 
Pancreatic Cancer Resulting in Higher Pancreatic Cancer Survival Rates 
  
  
Symptoms of pancreatic cancer can include: dark urine and 
  clay-colored stools, fatigue and weakness, jaundice (a yellow color in the 
  skin, mucus membranes, or eyes), loss of appetite and weight loss, nausea 
  and vomiting, pain or discomfort in the upper part of the belly or abdomen, 
  back pain, blood clots, diarrhea, and indigestion.
Pancreatic cancer is often not detected 
          early on and is often advanced when it is first found.  
          As such, ninety-five percent of the people diagnosed with 
          this cancer will not be alive 5 years later.  Some 
          patients have pancreatic cancer that can be surgically 
          removed are cured. However, in more than 80% of patients the 
          tumor has already spread and cannot be completely removed at 
          the time of diagnosis.  In the few cases where 
          pancreatic tumors can be removed by surgery. The standard 
          surgical procedure to remove pancreatic tumors is called a 
          Whipple procedure (pancreatoduodenectomy or 
          pancreaticoduodenectomy). This surgery should be done by an 
          experienced surgeon and at a medical center that performs 
          the procedure often. Some studies suggest that the Whipple 
          procedure is best performed at hospitals that do more than 
          five of these surgeries per year. 
When the tumor has not spread out of the 
          pancreas, but cannot be removed, radiation therapy and 
          chemotherapy together may be recommended. When the tumor has 
          spread (metastasized) to other organs such as the liver, 
          chemotherapy alone is usually used. The standard 
          chemotherapy drug is gemcitabine, but other drugs may be 
          used. Gemcitabine can help about 25% of patients. 
Patients whose tumor cannot be totally 
          removed, but who have a blockage of the tubes that transport 
          bile (biliary obstruction) must have that blockage relieved. 
          There are two approaches including surgery and placement of 
          a tiny metal tube (biliary stent) during ERCP. 
Managing pain and other symptoms is an 
          important part of treating advanced pancreatic cancer. 
          Palliative care tams and hospice can help with pain and 
          symptom management, and provide psychological support for 
          patients and their families during the illness.
        
Incretin Diabetes Drugs May Cause An Increased Risk of Pancreatic Cancer  
Diabetes drugs in the incretin mimetic class may cause an increased 
health risk of pancreatic cancer and pancreatitis.  These incretin 
diabetes drug include exenatide (Byetta, Bydureon), liraglutide 
(Victoza), sitagliptin (Januvia, Janumet, Janumet XR, Juvisync), 
saxagliptin (Onglyza, Kombiglyze XR), alogliptin (Nesina, Kazano, 
Oseni), and linagliptin (Tradjenta, Jentadueto). These drugs work by 
mimicking the incretin hormones that the body usually produces naturally
 to stimulate the release of insulin in response to a meal. They are 
used along with diet and exercise to lower blood sugar in adults with 
type 2 diabetes.  Many of these incretin diabetes drugs already include a
 black box warning regarding thyroid cancer risk, but evidence is 
growing that these drugs may also create an increased risk of pancreatic
 cancer. People that are taking incretin diabetes drugs including: Januvia, 
Janument, Victoza, Byetta, Onglyza, Tradjenta,  Oseni, and other 
diabetes drugs should be aware of the cancer health risks.